Tag: paul_naske
-
Rua Bioscience Shareholders Back Board Nominees and 69.6m Share Issue at 2026 Annual Meeting
Rua Bioscience shareholders passed all six ordinary resolutions at its virtual annual meeting, re-electing three directors, electing Qi (Keith) Zhou and authorising up to 69,635,032 new shares at no less than $0.03 each.
BusinessFinancial MarketsGeneral Politics Rua BioscienceAnnual Shareholders' MeetingNZXshare issuedirector electionQi (Keith) ZhouPaul Naske
-
Rua Bioscience Reports 53% Revenue Growth but Warns Working Capital Is "Immediate Constraint"
Rua Bioscience posts $2.9m total revenue, up 53%, and a narrowing operating loss at its 2026 annual meeting, but says funding inventory for its $10m-plus UK Curaleaf deal is now its biggest challenge.
BusinessHealthUnited KingdomCanadaEconomyFinancial MarketsMedical ScienceTradeEurope Rua BioscienceAnna StovePaul Naskemedicinal cannabisCuraleafannual shareholders meeting
-
Rua Bioscience signs UK distribution deal with Curaleaf Laboratories
Rua Bioscience has signed a sales and distribution agreement with Curaleaf Laboratories, giving the NZX-listed company an established route into the UK medicinal cannabis market.
BusinessHealthUnited KingdomTradeFinancial MarketsEurope Rua BioscienceCuraleaf Laboratoriesmedicinal cannabisNZXPaul NaskeTairāwhiti